Financial Data & APIs
Membership is Free
What are you waiting for? Sign up now!
Free Account Login
Click here to access your premium account
Username or email:
Benzinga - Feed Your Mind.
Best of Benzinga
Benzinga Fintech Awards
From The Press
Search by keyword...
Benzinga Staff Writer
January 17, 2013 2:01 PM
Apple Underperforming Biggest Rivals
Over the last few months, Apple (NASDAQ: AAPL) has -- to put it lightly -- been disappointing to those with $1000 price targets. Along with it, the NA ...
January 17, 2013 11:49 AM
VF Corporation Tries to Ensnare Billabong
Billabong International (ASX: BBG), best known for their surf apparel, was offered $556 million USD recently in a takeover offer by VF Corporation (NY ...
January 17, 2013 10:41 AM
Apple Options Skew: An Earnings Indicator?
Contrarian traders, by nature, tend to fade the prevailing market norm. According to some, when the options market gets too bearish one should get bu ...
January 14, 2013 9:43 AM
Breaking Down Baidu's Technicals
Baidu (NASDAQ: BIDU) shares have bounced over 30 percent after touching the bottom of its trend channel. The powerful hanging man candle proved to be ...
January 11, 2013 1:34 PM
PPG Earnings Preview and an Options Trade Around It
Chemical giant PPG (NYSE: PPG) will report earnings on Monday before the opening bell. It might not be the flashiest stock, but it still offers trader ...
January 10, 2013 2:16 PM
Selling ATM Straddles Around the Fiscal Cliff Could've Netted Traders 36%
Selling the "at the money" (ATM) straddle in the S&P 500 ETF (NYSE: SPY) during the countdown to the fiscal cliff may have put some grey hair on t ...
Spectrum Pharma Reports Initiation of Phase 2 Trial of Poziotinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
Opus Bank Reports Growth Equity Investment by Bank-Sponsored SBIC Fund in Leading Bridge & Highway Infrastructure Co.
Morgan Stanley Downgrades Cypress Semiconductor To Underweight
RXi Pharma Reports Q4 EPS $(0.60) vs $(0.40) in Same Qtr. Last Year
Susquehanna Downgrades Lululemon Athletica To Neutral
Wells Fargo Downgrades Lululemon Athletica To Market Perform
Vince McMahon's 5 Biggest Business Flops
UPDATE: Omeros Reports New Data 'corroborate and expand on trial results reported in Q4'16'
Omeros Reports Data in OMS721 Phase 2 Trial in Renal Diseases
AbbVie Reports FDA Approval of Addition to Moderate to Severe Fingernail Psoriasis Data to Co.'s HUMIRA Prescribing Information
UBS Upgrades Range Resources To Buy
Wall Street's M&A Chatter From March 29: Cabela's, WebMD, MaxLinear-Exar
UBS Upgrades EOG Resources To Buy, Raises Price Target To $109
Karyopharm Therapeutics Reports FDA Division of Hematology Products Lifts Partial Clinical Hold on Selinexor Trials
Canadian Solar Reports Securing of JPY4B Credit Facility with Sumitomo Mitsui Finance and Leasing
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.
Be Your Own Boss
Tools & Features
Real Time Feed
Submit News Tips
Licensing and APIs
Apps (iOS and Android)
In the News
Terms and Conditions
1 (877) 440-9464 (ZING)
© Copyright Benzinga
Benzinga - Feed Your Mind